BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9349527)

  • 1. The role of glutathione in dopaminergic neuronal survival.
    Nakamura K; Wang W; Kang UJ
    J Neurochem; 1997 Nov; 69(5):1850-8. PubMed ID: 9349527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of 1,25-dihydroxyvitamin D(3) on cultured mesencephalic dopaminergic neurons to the combined toxicity caused by L-buthionine sulfoximine and 1-methyl-4-phenylpyridine.
    Shinpo K; Kikuchi S; Sasaki H; Moriwaka F; Tashiro K
    J Neurosci Res; 2000 Nov; 62(3):374-82. PubMed ID: 11054806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferential resistance of dopaminergic neurons to the toxicity of glutathione depletion is independent of cellular glutathione peroxidase and is mediated by tetrahydrobiopterin.
    Nakamura K; Wright DA; Wiatr T; Kowlessur D; Milstien S; Lei XG; Kang UJ
    J Neurochem; 2000 Jun; 74(6):2305-14. PubMed ID: 10820190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutathione depletion potentiates MPTP and MPP+ toxicity in nigral dopaminergic neurones.
    Wüllner U; Löschmann PA; Schulz JB; Schmid A; Dringen R; Eblen F; Turski L; Klockgether T
    Neuroreport; 1996 Mar; 7(4):921-3. PubMed ID: 8724674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered glial function causes neuronal death and increases neuronal susceptibility to 1-methyl-4-phenylpyridinium- and 6-hydroxydopamine-induced toxicity in astrocytic/ventral mesencephalic co-cultures.
    McNaught KS; Jenner P
    J Neurochem; 1999 Dec; 73(6):2469-76. PubMed ID: 10582607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The selective toxicity of 1-methyl-4-phenylpyridinium to dopaminergic neurons: the role of mitochondrial complex I and reactive oxygen species revisited.
    Nakamura K; Bindokas VP; Marks JD; Wright DA; Frim DM; Miller RJ; Kang UJ
    Mol Pharmacol; 2000 Aug; 58(2):271-8. PubMed ID: 10908294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection from 1-methyl-4-phenylpyridinium (MPP+) toxicity and stimulation of regrowth of MPP(+)-damaged dopaminergic fibers by treatment of mesencephalic cultures with EGF and basic FGF.
    Park TH; Mytilineou C
    Brain Res; 1992 Dec; 599(1):83-97. PubMed ID: 1362921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lazaroid treatment prevents death of cultured rat embryonic mesencephalic neurons following glutathione depletion.
    Grasbon-Frodl EM; Andersson A; Brundin P
    J Neurochem; 1996 Oct; 67(4):1653-60. PubMed ID: 8858950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preferential resistance of dopaminergic neurons to glutathione depletion in a reconstituted nigrostriatal system.
    Nakamura K; Won L; Heller A; Kang UJ
    Brain Res; 2000 Aug; 873(2):203-11. PubMed ID: 10930545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caspase inhibitors attenuate 1-methyl-4-phenylpyridinium toxicity in primary cultures of mesencephalic dopaminergic neurons.
    Bilsland J; Roy S; Xanthoudakis S; Nicholson DW; Han Y; Grimm E; Hefti F; Harper SJ
    J Neurosci; 2002 Apr; 22(7):2637-49. PubMed ID: 11923429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depletion of intracellular glutathione increases susceptibility to nitric oxide in mesencephalic dopaminergic neurons.
    Ibi M; Sawada H; Kume T; Katsuki H; Kaneko S; Shimohama S; Akaike A
    J Neurochem; 1999 Oct; 73(4):1696-703. PubMed ID: 10501217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glial cell line-derived neurotrophic factor exerts neurotrophic effects on dopaminergic neurons in vitro and promotes their survival and regrowth after damage by 1-methyl-4-phenylpyridinium.
    Hou JG; Lin LF; Mytilineou C
    J Neurochem; 1996 Jan; 66(1):74-82. PubMed ID: 8522992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1-methyl-4-phenylpyridinium-induced alterations of glutathione status in immortalized rat dopaminergic neurons.
    Drechsel DA; Liang LP; Patel M
    Toxicol Appl Pharmacol; 2007 May; 220(3):341-8. PubMed ID: 17395226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-deprenyl fails to protect mesencephalic dopamine neurons and PC12 cells from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion.
    Vaglini F; Pardini C; Cavalletti M; Maggio R; Corsini GU
    Brain Res; 1996 Nov; 741(1-2):68-74. PubMed ID: 9001706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levodopa is toxic to dopamine neurons in an in vitro but not an in vivo model of oxidative stress.
    Mytilineou C; Walker RH; JnoBaptiste R; Olanow CW
    J Pharmacol Exp Ther; 2003 Feb; 304(2):792-800. PubMed ID: 12538835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of oxidative stress and the glutathione system in loss of dopamine neurons due to impairment of energy metabolism.
    Zeevalk GD; Bernard LP; Nicklas WJ
    J Neurochem; 1998 Apr; 70(4):1421-30. PubMed ID: 9523558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of extracellular signal-regulated protein kinase in neuronal cell death induced by glutathione depletion in neuron/glia mesencephalic cultures.
    de Bernardo S; Canals S; Casarejos MJ; Solano RM; Menendez J; Mena MA
    J Neurochem; 2004 Nov; 91(3):667-82. PubMed ID: 15485497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson's disease?
    Hartmann A; Michel PP; Troadec JD; Mouatt-Prigent A; Faucheux BA; Ruberg M; Agid Y; Hirsch EC
    J Neurochem; 2001 Mar; 76(6):1785-93. PubMed ID: 11259496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of creatine treatment on the survival of dopaminergic neurons in cultured fetal ventral mesencephalic tissue.
    Andres RH; Huber AW; Schlattner U; Pérez-Bouza A; Krebs SH; Seiler RW; Wallimann T; Widmer HR
    Neuroscience; 2005; 133(3):701-13. PubMed ID: 15890457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversible inhibition of mitochondrial complex I activity following chronic dopaminergic glutathione depletion in vitro: implications for Parkinson's disease.
    Chinta SJ; Andersen JK
    Free Radic Biol Med; 2006 Nov; 41(9):1442-8. PubMed ID: 17023271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.